JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 51 filers reported holding JANUX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,942,265 | -12.6% | 192,685 | +2.9% | 0.00% | – |
| Q2 2023 | $2,223,132 | +31.3% | 187,290 | +33.8% | 0.00% | – |
| Q1 2023 | $1,693,650 | -8.0% | 139,971 | +0.2% | 0.00% | – |
| Q4 2022 | $1,840,218 | -0.4% | 139,728 | +2.5% | 0.00% | – |
| Q3 2022 | $1,847,000 | +13.7% | 136,364 | +2.4% | 0.00% | – |
| Q2 2022 | $1,625,000 | -19.2% | 133,157 | -5.1% | 0.00% | – |
| Q1 2022 | $2,011,000 | -11.8% | 140,247 | +21.4% | 0.00% | – |
| Q4 2021 | $2,279,000 | -9.9% | 115,495 | -1.3% | 0.00% | – |
| Q3 2021 | $2,530,000 | – | 116,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $216,333,000 | 3.47% |
| 5AM Venture Management, LLC | 446,266 | $11,134,000 | 2.80% |
| Samsara BioCapital, LLC | 607,949 | $15,168,000 | 1.87% |
| EcoR1 Capital, LLC | 1,411,975 | $35,229,000 | 1.32% |
| Logos Global Management LP | 547,122 | $13,651,000 | 1.15% |
| BVF INC/IL | 1,176,681 | $29,358,000 | 1.10% |
| Orbimed Advisors | 3,466,386 | $86,486,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 700,000 | $17,465,000 | 0.31% |
| Pinz Capital Management, LP | 32,100 | $801,000 | 0.24% |
| Woodline Partners LP | 334,260 | $8,340,000 | 0.16% |